Doctor-patient communication and pressure under scrutiny

1 October 2006

Two US surveys into doctor-patient relationships have found that "doctors are doing a poor job at communicating critical information about the medications they prescribe," according to researchers at the University of California Los Angeles, but that most doctors are also under pressure from parents to prescribe behavioral drugs to children in order to boost academic performance.

The first survey was carried out by audiotaping 185 patient visits to 16 family physicians, 18 internists and 11 cardiologists in Sacramento, California, over an 11-month period. The data showed that doctors explained the purpose of a new medication to patients 87% of the time. However, they named the product to patients in 74% of cases, while discussions of potential adverse effects were restricted to 35% of occasions.

Patients were only told by their physician how long a drug treatment course should last in 34% of cases, 55% were told how many tablets to take. Information on how often or when patients should take a dose was provided in 58% of instances.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight